BioRN Lounge with Cristina Grigore from LONZA AG
top of page
Search
The guest speaker of BioRN Lounge on April 25 was Cristina Grigore, Customer Proposals Professional at LONZA AG. Cristina guided a very...
- Apr 21, 2023
- 3 min
Novaliq announces publication of second pivotal phase 3 trial data on CyclASol®
Novaliq announces publication of second pivotal phase 3 trial data on CyclASol® 0.1% (Cyclosporine Ophthalmic Solution) in JAMA...
- Apr 21, 2023
- 3 min
N2B-Patch – Development of an intranasal form of therapy for the treatment of multiple sclerosis
Biomaterials for treatment of demyelination disorders of the central nervous system Effective drugs for the treatment of diseases of the...
- Apr 21, 2023
- 1 min
Germany Life Science Trend Analysis 2023
After two strong years driven by the global pandemic, the German life sciences industry did not perform as well in terms of equity...
- Apr 21, 2023
- 2 min
Ascendis Pharma’s Initial Dose Escalation Results Accepted for Online Publication at ASCO 2023
Ascendis Pharma’s Initial Dose Escalation Results from the Ongoing Phase 1/2 Trial of TransCon™ IL-2 β/γ Accepted for Online Publication...
- Apr 21, 2023
- 2 min
Alternative glucose breakdown ensures the survival of cancer cells
A key enzyme in sugar metabolism is inactivated particularly easily and efficiently by oxidative stress. Scientists at the German ...
- Apr 21, 2023
- 2 min
Heidelberg Pharma Presents New Preclinical Data at AACR Annual Meeting 2023
Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023 Ladenburg,...
- Apr 21, 2023
- 1 min
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19
Sciomics are proud to announce the publication of their study on disease severity markers in Covid-19 in Communications Medicine. They ...
- Apr 21, 2023
- 1 min
Heidelberg "Young" Biotech turns forty
Caroline Odenwald, Head of Marketing at PROGEN talked with us about the dynamic development of one of the oldest German biotech...
- Apr 18, 2023
- 1 min
New Member: Welcome in our cluster to ARXUM
ARXUM® is a deep-tech blockchain technology company offering advanced infrastructure and versatile middleware that reduces the complexity...
- Apr 6, 2023
- 5 min
Targeting the protective shield of cancers
Cancer cells have different mechanisms to help them escape destruction by the immune system. Solid tumours, for example, are often...
- Apr 6, 2023
- 2 min
BioMed X and Merck Expand Collaboration
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies After successfully...
bottom of page